Sign in

CIK 0001582554

  • Non-accelerated filer
  • Smaller reporting company

Matinas BioPharma Holdings, Inc.

Sign in to watch
Ticker
MTNB
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463011414
Phone
+1 908-484-8805
Business address
1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-06 NEUGEBOREN EDWARD Director Grant or award · Stock Option (right to Buy) +5,000 5,000
2026-11-06 NEUGEBOREN EDWARD Director Grant or award · Stock Option (right to Buy) +5,000 5,000
2025-04-30 NEUGEBOREN EDWARD Director Grant or award · Stock Option (right to Buy) +11,600 11,600

Page 1 of 1 · 3 trades